The Market Information for Access initiative (MI4A) was launched in 2018 to contribute to the achievement of Strategic Development Goal 3.8 (Universal Health Coverage target) by enhancing access to safe, effective, quality and affordable vaccines for all. This important matter has been highlighted by the World Health Assembly in 2019 with the endorsement of a Roadmap for Access to medicines and vaccines and the adoption of Resolution WHA 72.8 on improving the transparency of markets for medicines, vaccines and other health products.
MI4A is a peer platform that leverages vaccine purchase data collected from countries and provides it publicly to inform product choice, conduct financial planning, optimize budgets, enhance procurement and strengthen national and regional capacity for improved access to vaccines. The data is also analyzed globally to enhance understanding of vaccine market dynamics and work towards universal access in service to the Immunization Agenda 2030. Vaccine manufacturers also participate by sharing information on their late-stage pipeline and available supply, as well as by engaging in dialogue to inform investment decisions. More information on MI4A can be found here.
Further information on the call for experts, including how to apply, is linked below. Applications are due February 12th, 2023.
Learn more